In conclusion, the combination of GH-RH and LH-RH antagonists potentiated reduction of rat prostate weight and synergistically inhibits growth of BPH-1 cells leading to cell cycle arrest in S-phase93. Here, GHRH is linked to benign prostatic hyperplasia.